로딩 중…
StockDiggingStockDigging

Balchem Corporation

BCPC· NASDAQ
$170.07-0.19%
2026-10-30

Financials

Valuation Metrics

Balchem Corporation's Market Cap is $5.46B. At end of 2025 it was $4.96B. Ranked #1284 of 3,116 in US market (top 41%), #428 of 1,472 on NASDAQ (top 29%), #78 of 173 in Materials (top 45%) by Market Cap.

Investment Metrics(as of 2026-10-30)

MetricValue
Size
Market Cap$5.46B
Revenue$1.11B
Net Income$171M
Total Assets$1.70B
Net Assets$1.33B
Employees1,352
Value
P/E31.98x
P/B4.12x
PEG2.20x
P/S4.93x
EV/EBITDA20.14x
FCF Yield3.80%
Profitability
ROE12.88%
ROA10.03%
Op. Margin21.40%
Revenue Growth9.42%
Earnings Growth14.51%
Financial Health
Debt Ratio28.40%
Total Debt$142M
FCF$208M
Cash$66M
Current Ratio2.47x
Net Debt/EBITDA0.28x
Dividend
Div. Yield0.56%
Div. Growth9.68%
Performance
1Y Return11.14%
1M Return3.10%
From 52W High-7.52%
1Y MDD-14.71%
Trading
Volume158,468 shares
Trading Value$27M
Per Share
EPS$5.32
BPS$41.29

Company Info

CEO Mr. Theodore Lee Harris
Employees 1,352
HQ Montvale, United States

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.